Glenmark Life Sciences Limited had a revenue of 5.88B in the quarter ending Sep 30, 2024, with -0.11%. This bring the company's revenue in the last twelve months to 11.91B, Decreased 0.05%. In the fiscal year ending Mar 31, 2025, Glenmark Life Sciences Limited had annual revenue of 25.52B with 11.76% growth.